LawWiki
HomeCodesSearchGlossaryAPIAbout
LawWiki

Plain English summaries of California law with zero-hallucination AI. Every summary is verified against official source text.

Product

  • Search
  • Codes
  • About

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

© 2026 LawWiki. All rights reserved.

HomeHealth and Safety CodeDiv. 104Pt. 5Ch. 4Art. 4§ 110423 Ephedra Supplement Labeling Rules

§ 110423 Ephedra Supplement Labeling Rules

Health and Safety Code·California
AI Summary·Official Text·Key Terms·Related Statutes·References
AI SummaryVerified

§ 110423 Ephedra Supplement Labeling Rules

Key Takeaways

  • •If you sell supplements with ephedrine (a stimulant), the label must say exactly how much is in each serving.
  • •The label must also have big warnings: no kids, no pregnant people, and a list of health problems where this supplement is dangerous.
  • •If the supplement has steroid-like stuff, the label must warn about side effects like acne, hair loss, and mood swings.
  • •Every label must have a phone number (1-800-332-1088) to report bad reactions.

Example

You buy a weight-loss pill at the store that has ephedrine in it.

The bottle must say how many milligrams of ephedrine are in one pill. It must also have a big warning saying kids and pregnant people can’t take it, and if your heart races or you feel dizzy, stop and call a doctor. If it doesn’t have these warnings, the store shouldn’t be selling it.

AI-generated — May contain errors. Not legal advice. Always verify source.

Official Source
View on CA.gov

§ 110423 Ephedra Supplement Labeling Rules

(a)  (1)  The sale or distribution of any dietary supplement product containing ephedrine group alkaloids is prohibited unless the product label clearly and conspicuously contains the following statement: “THIS PRODUCT HAS (INSERT THE AMOUNT OF PRODUCT) MILLIGRAMS OF CONCENTRATED EPHEDRINE GROUP ALKALOIDS PER SERVING IN THE FORM OF HERBAL EXTRACTS.” (2)  The sale or distribution of any dietary supplement product containing ephedrine group alkaloids is prohibited unless the product label clearly and conspicuously contains the following warning: (A)  “WARNING: NOT FOR USE BY INDIVIDUALS UNDER THE AGE OF 18 YEARS. DO NOT USE IF PREGNANT OR NURSING. Consult a physician or licensed qualified health care professional before using this product if you have, or have a family history of, heart disease, thyroid disease, diabetes, high blood pressure, depression or other psychiatric condition, glaucoma, difficulty in urinating, prostate enlargement, or seizure disorder, or if you are using a monoamine oxidase inhibitor (MAOI) or any other dietary supplement, prescription drug, or over-the-counter drug containing ephedrine, pseudoephedrine, or phenylpropanolamine (ingredients found in certain allergy, asthma, cough or cold, and weight control products).” (B)  “Do not exceed recommended serving. Exceeding recommended serving may cause serious adverse health effects, including heart attack and stroke.” (C)  “Discontinue use and call a physician or licensed qualified health care professional immediately if you experience rapid heartbeat, dizziness, severe headache, shortness of breath, or other similar symptoms.” (D)  “Individuals who are sensitive to the effects of caffeine should consult a licensed health care professional before consuming this product.” (E)  “KEEP OUT OF REACH OF CHILDREN.” (b)  The sale or distribution of dietary supplements containing steroid hormone precursors is prohibited unless the product label for these dietary supplements clearly and conspicuously contains the following warning: “WARNING: NOT FOR USE BY INDIVIDUALS UNDER THE AGE OF 18 YEARS. DO NOT USE IF PREGNANT OR NURSING. Consult a physician or licensed qualified health care professional before using this product if you have, or have a family history of, prostate cancer, prostate enlargement, heart disease, low “good” cholesterol (HDL), or if you are using any other dietary supplement, prescription drug, or over-the-counter drug. Do not exceed recommended serving. Exceeding recommended serving may cause serious adverse health effects. Possible side effects include acne, hair loss, hair growth on the face (in women), aggressiveness, irritability, and increased levels of estrogen. Discontinue use and call a physician or licensed qualified health care professional immediately if you experience rapid heartbeat, dizziness, blurred vision, or other similar symptoms. KEEP OUT OF REACH OF CHILDREN.” (c)  The product label for any dietary supplement product containing ephedrine group alkaloids or steroid hormone precursors shall clearly and conspicuously display the following statement: “To report any adverse events call 1-800-332-1088.” (Added by Stats. 2002, Ch. 1005, Sec. 1. Effective January 1, 2003.)

Last verified: January 23, 2026

Key Terms

prescriptiondistributionsupplementhealthmedicallicensephysiciannursing

Related Statutes

  • § 11150 Prescription Authority Restrictions
  • § 11167.5 Controlled Substance Prescription Rules
  • § 128297 Certified Nurse-Midwife Training Definitions
  • § 1797.273 Community Paramedicine Advisory Committee
  • § 1315 Dental Services In Health Facilities

References

  • Official text at leginfo.legislature.ca.gov
  • California Legislature. Health and Safety Code. Section 110423.
View Official Source